InSitu Technologies Secures Drug License to Support In-House Stent Coating Capability

InSitu Technologies (Pvt) Limited has been granted a drug sale license by the licensing authority in Pakistan, permitting the company to sell, stock, and distribute registered pharmaceutical products under the Drug Act, 1976. The license covers the company's premises at RCCI Industrial Estate, Rawat, and is valid through 2031.

For InSitu, this license supports something specific: the ability to handle drug substance in-house as part of its drug-eluting stent coating process. It's a small but important piece of building end-to-end manufacturing capability in Pakistan.